NEW YORK, Dec 18 – Zyomyx and MDS Proteomics said Monday they had agreed to jointly study protein pathways as part of an effort to improve cell research.

Under the terms of the deal, Zyomyx will contribute its protein chip technology and MDS will contribute its protein pathway identification and analysis experience to prove the efficacy of using protein biochips in mass spectrometry-based proteomic studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.